How do I buy Immuneering (IMRX) stock?

You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.View our list of the best stock brokerages

Who are Immuneering (IMRX) competitors?

Other companies in Immuneering’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Larimar Therapeutics Inc (NASDAQ:LRMR), PepGen Inc (NASDAQ:PEPG), AC Immune SA (NASDAQ:ACIU) and Neurogene Inc (NASDAQ:NGNE).

What is the forecast, or price target, for Immuneering (IMRX) stock?

Immuneering has a consensus price target of $15.90.

What is the current price for Immuneering (IMRX)?

The stock price for Immuneering (NASDAQ: IMRX) is $5.37 last updated January 23, 2026 at 7:58 PM EST.

Does Immuneering (IMRX) pay a dividend?

There are no upcoming dividends for Immuneering.

When is Immuneering (NASDAQ:IMRX) reporting earnings?

Immuneering does not have any upcoming earnings scheduled.

Is Immuneering (IMRX) going to split?

There is no upcoming split for Immuneering.

What sector and industry does Immuneering (IMRX) operate in?

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immuneering (IMRX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

Comments